Literature DB >> 11142417

Intention to be tested for prostate cancer risk among African-American men.

R E Myers1, T Hyslop, K Jennings-Dozier, T A Wolf, D Y Burgh, J A Diehl, C Lerman, G W Chodak.   

Abstract

This study was conducted to identify factors associated with intention to be tested for prostate cancer risk among African-American men. Participants in this study included African-American men (n = 548) who were patients at the University Health Service at the University of Chicago, were 40 to 70 years of age, and did not have a personal history of prostate cancer. Baseline telephone survey data were collected for 413 (75%) men. Respondents were asked if they intended to have a blood test to assess prostate cancer risk. Univariate and multivariate analyses of intention to be tested for risk were performed. Eighty-six percent of the men said that they intended to be tested. Multivariate analysis results show that belief in the efficacy of prostate cancer screening [odds ratio (OR) = 3.6; 95% confidence interval (CI) = 1.4, 9.1] and intention to undergo a prostate cancer-screening (i.e., digital rectal examination and prostate-specific antigen testing; OR = 2.8; 95% CI = 1.3, 6.3) were positively associated with intention to be tested for prostate cancer risk. Being older (OR = 0.4; 95% CI = 0.2, 0.9), having had a prostate cancer-screening examination in the past year (OR = 0.5; 95% CI = 0.2, 1.0), perceiving one's prostate cancer susceptibility to be high (OR = 0.4; 95% CI = 0.2, 0.8), and being fatalistic about prostate cancer prevention (OR = 0.3; 95% CI = 0.2, 0.7) were negatively associated with intention to be tested for risk. Intention to be tested for prostate cancer risk was high among men in the study. Past screening, perceived susceptibility, and beliefs related to early detection might influence receptivity to genetic testing for prostate cancer risk.

Entities:  

Mesh:

Year:  2000        PMID: 11142417

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  18 in total

1.  The Reliability and Validity of the Religious Health Fatalism Scale in Turkish Language.

Authors:  Gulruz Bobov; Canturk Capik
Journal:  J Relig Health       Date:  2020-04

Review 2.  Predictors of genetic testing decisions: a systematic review and critique of the literature.

Authors:  Kate Sweeny; Arezou Ghane; Angela M Legg; Ho Phi Huynh; Sara E Andrews
Journal:  J Genet Couns       Date:  2014-04-11       Impact factor: 2.537

3.  Leveraging the Family Influence of Women in Prostate Cancer Efforts Targeting African American Men.

Authors:  O N Okoro; C A Rutherford; S F Witherspoon
Journal:  J Racial Ethn Health Disparities       Date:  2017-08-25

4.  Perceived ambiguity about cancer prevention recommendations: associations with cancer-related perceptions and behaviours in a US population survey.

Authors:  Paul K J Han; Richard P Moser; William M P Klein
Journal:  Health Expect       Date:  2007-12       Impact factor: 3.377

5.  The Reliability and Validity of Prostate Cancer Fatalism Inventory in Turkish Language.

Authors:  Nihal Gördes Aydoğdu; Cantürk Çapık; Fatma Ersin; Aygul Kissal; Zuhal Bahar
Journal:  J Relig Health       Date:  2017-10

6.  The Eastland Prostate Cancer Survey: instrument development and psychometric testing.

Authors:  Taryn Y Eastland; Barbara L Dancy
Journal:  J Cancer Educ       Date:  2013-03       Impact factor: 2.037

7.  Perceived family history risk and symptomatic diagnosis of prostate cancer: the North Carolina Prostate Cancer Outcomes study.

Authors:  Pamela Spain; William R Carpenter; James A Talcott; Jack A Clark; Young Kyung Do; Robert J Hamilton; Joseph A Galanko; Anne Jackman; Paul A Godley
Journal:  Cancer       Date:  2008-10-15       Impact factor: 6.860

8.  Racial differences in prostate cancer screening by family history.

Authors:  Bettina F Drake; Christopher S Lathan; Cassandra A Okechukwu; Gary G Bennett
Journal:  Ann Epidemiol       Date:  2008-05-16       Impact factor: 3.797

9.  Cancer-specific beliefs and survival in nonmetastatic colorectal cancer patients.

Authors:  Hosanna Soler-Vilá; Robert Dubrow; Vivian I Franco; Andrea K Saathoff; Stanislav V Kasl; Beth A Jones
Journal:  Cancer       Date:  2009-09-15       Impact factor: 6.860

10.  Intrinsic religiousness as a mediator between fatalism and cancer-specific fear: clarifying the role of fear in prostate cancer screening.

Authors:  Lisa K Christman; Alexis D Abernethy; Richard L Gorsuch; Allan Brown
Journal:  J Relig Health       Date:  2014-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.